The Dexamethasone Sodium Phosphate 0.11%/Sulfacetamide 10% Topical Liquid is a specially compounded preparation intended for external application. This dual-action formulation combines the anti-inflammatory and immunosuppressive properties of Dexamethasone Sodium Phosphate with the antibacterial efficacy of Sulfacetamide. It is designed to deliver targeted relief and treatment directly to the affected skin or mucosal areas, minimizing systemic absorption and potential side effects.
This topical liquid is primarily used in the management of dermatological conditions such as eczematous dermatitis, contact dermatitis, and seborrheic dermatitis. The formulation's liquid form allows for easy application and rapid absorption on both skin and mucosal surfaces, providing prompt therapeutic action in the treatment of these disease states.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dexamethasone Sodium Phosphate 0.11%/Sulfacetamide 10% Topical Liquid is a specialized compound that combines the anti-inflammatory and immunosuppressive properties of Dexamethasone Sodium Phosphate with the antibacterial efficacy of Sulfacetamide. This topical solution is meticulously prepared to ensure uniformity and stability.
Dexamethasone, a potent corticosteroid, works by reducing inflammation and suppressing the immune response at the site of application. This makes it particularly useful in treating inflammatory skin disorders such as eczema, psoriasis, and dermatitis. Its immunosuppressive action also aids in managing autoimmune skin diseases where excessive immune response is a contributing factor.
Sulfacetamide, on the other hand, is a sulfonamide antibiotic that inhibits the growth of bacteria by interfering with folic acid synthesis, an essential process for bacterial proliferation.
The combination of these two agents in a topical liquid form allows for direct application to affected areas, ensuring high local concentrations of the drugs while minimizing systemic absorption and potential side effects. This is particularly advantageous for patients who require localized treatment or those for whom systemic therapy is contraindicated or undesirable.
Patients and prescribers should be aware that this formulation is intended for external use only and should be applied as directed by a healthcare professional. It is important to use this medication for the full prescribed duration, even if symptoms improve, to prevent the recurrence of infection. Patients should be advised to avoid contact with eyes, and in the case of accidental contact, the area should be rinsed thoroughly with water.
As with any medication, there may be potential side effects, including local irritation, redness, or itching at the site of application. Patients should be instructed to report any adverse reactions or signs of hypersensitivity. It is also essential to discuss any current medications or underlying health conditions with a healthcare provider before starting treatment with this compound to avoid potential drug interactions or contraindications.
Bayview Pharmacy is committed to providing high-quality compounded medications tailored to meet individual patient needs. Our team of expert compounding pharmacists is available to answer any questions and provide guidance on the use of Dexamethasone Sodium Phosphate 0.11%/Sulfacetamide 10% Topical Liquid. If you have any questions or require further information, please do not hesitate to reach out to us.
The combination of Dexamethasone Sodium Phosphate and Sulfacetamide in a topical liquid formulation is used primarily for its anti-inflammatory and antibacterial properties, respectively. Dexamethasone is a potent corticosteroid that can reduce inflammation and suppress the immune response in the area of application. Sulfacetamide is a sulfonamide antibiotic that can inhibit the growth of bacteria by interfering with folic acid synthesis. This combination is often used to treat skin conditions such as dermatitis, eczema, or certain bacterial skin infections where both inflammation and bacterial overgrowth are concerns.
When considering drug interactions, it is important to note that while the systemic absorption of these agents is typically low when applied topically, there is still potential for interactions, particularly with prolonged use or over large surface areas. Dexamethasone, being a corticosteroid, may interact with other medications that suppress the immune system, potentially increasing the risk of infection. Patients should be cautious if they are also taking other corticosteroids, immunosuppressants, or have recently received a vaccine. Additionally, the use of other topical medications, especially those containing corticosteroids, should be managed carefully to avoid excessive steroid exposure.
Sulfacetamide may interact with medications that are also sulfonamides or that can cause similar side effects, such as diuretics (thiazides) or sulfonylureas (used in diabetes management). It is also important to consider potential cross-sensitivity reactions in patients with a known allergy to sulfonamide antibiotics or related compounds. Concurrent use of other topical antibiotics should be monitored to prevent additive effects and increased risk of local irritation or contact dermatitis.
Patients should be advised to inform their healthcare providers of all medications they are currently taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions. It is also important to use this medication only on the areas prescribed and for the duration specified by the healthcare provider to minimize the risk of systemic absorption and potential interactions.
For prescribers, it is crucial to review the patient's medication history for any drugs that may interact with corticosteroids or sulfonamides. Monitoring for signs of systemic side effects or hypersensitivity reactions is recommended, especially in patients with a history of allergies to sulfonamide drugs. Adjustments to therapy may be necessary if an interaction is suspected or if the patient experiences unusual side effects.
If you have any questions or require further information regarding the use of this formulation or potential drug interactions, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide support and guidance to ensure the safe and appropriate use of this medication.
The Dexamethasone Sodium Phosphate 0.11%/Sulfacetamide 10% Topical Liquid is a combination medication that harnesses the anti-inflammatory and antibacterial properties of its two active ingredients to treat a variety of dermatological and mucosal conditions. Dexamethasone Sodium Phosphate is a potent corticosteroid that works by reducing inflammation, redness, and swelling. It achieves this by inhibiting the release of substances in the body that cause inflammation. On the other hand, Sulfacetamide is a sulfonamide antibiotic that works by inhibiting the growth of bacteria on the skin, which helps to reduce infection and inflammation associated with bacterial skin infections or acne.
When applied topically, this combination medication provides localized treatment directly to the affected area. This allows for high concentrations of the active ingredients at the site of application while minimizing systemic absorption and potential side effects. The liquid formulation is particularly suitable for application to large or hairy areas of skin, as well as to mucosal surfaces where creams or ointments may not spread as easily.
The therapeutic effects of this formulation make it suitable for treating a range of conditions where both bacterial infection and inflammation are present. These may include certain types of dermatitis, acne, rosacea, or bacterial skin infections that also have an inflammatory component. By addressing both the bacterial and inflammatory aspects of these conditions, this topical liquid can help to alleviate symptoms and promote healing.
For optimal results, the formulation should be applied as directed by a healthcare provider, ensuring the affected area is clean and dry before application. The frequency and duration of treatment will depend on the specific condition being treated and the response to therapy. It is important to use this medication for the full prescribed length of time, even if symptoms improve before the medication is finished.
As with any medication, there may be potential side effects, and it is important to be aware of these. Patients should be advised to contact their healthcare provider if they experience any unusual symptoms or if their condition does not improve. Prescribers should consider the patient's medical history, potential drug interactions, and the severity of the condition when recommending this formulation.
If you have any questions or require further information about the Dexamethasone Sodium Phosphate 0.11%/Sulfacetamide 10% Topical Liquid, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to both patients and healthcare providers to ensure the safe and appropriate use of this medication.
While the primary indication for the Dexamethasone Sodium Phosphate 0.11%/Sulfacetamide 10% Topical Liquid is to provide anti-inflammatory and antibacterial effects for certain skin conditions, this formulation may offer additional therapeutic uses that can be beneficial in various clinical scenarios. For example, due to its anti-inflammatory component, it could be considered for the management of dermatoses that respond to corticosteroids, when secondary bacterial infection or risk of infection is also present. This might include certain eczematous dermatitis, psoriasis in areas susceptible to bacterial colonization, or insect bites where inflammation and bacterial infection are concerns.
In addition to the aforementioned conditions, this formulation may also serve as an adjunctive treatment for some wound care cases. The dexamethasone provides anti-inflammatory effects that could help reduce local swelling and irritation during the healing process, while the sulfacetamide acts as an antimicrobial agent, potentially preventing or managing superficial infections. It's important to note however that the use in open wounds should be approached with caution, considering the sensitivity of the tissue and the potential for systemic absorption, especially in large wounds or in cases where the skin barrier is significantly compromised.
The topical liquid form of this medication may also prove advantageous in certain mucosal inflammatory conditions, such as oral or ocular inflammation, especially when they are accompanied by bacterial infections that are sensitive to sulfacetamide. However, if considering such an application, it is imperative to consult with a healthcare provider, as this off-label use necessitates a professional's judgement and may require modification of the formulation to suit these specific environments.
Outside of dermatological and mucosal applications, there might be potential for experimenting with this combination in treating localized inflammatory ailments that benefit from topical steroids and have associated bacterial concerns. At this time, we encourage healthcare providers and patients to consider that the uses beyond the primary indications are largely empirical and should be embarked upon under the guidance and close supervision of a qualified healthcare professional.
For safety and efficacy reasons, it is crucial to avoid using this topical liquid in cases of viral, fungal, or tuberculosis skin lesions, or in individuals with known hypersensitivity to corticosteroids or sulfonamides. Any exploration of alternative uses should be thoroughly discussed with a healthcare provider, taking into account the patient's medical history and the potential for adverse reactions. If you have any questions or require further information on the potential uses of Dexamethasone Sodium Phosphate 0.11%/Sulfacetamide 10% Topical Liquid, please reach out to us at Bayview Pharmacy for personalized assistance and guidance.
Dexamethasone Sodium Phosphate 0.11%/Sulfacetamide 10% Topical Liquid is a medicated solution used for treating inflammatory skin conditions that may also involve bacterial infection. It combines an anti-inflammatory steroid with an antibacterial component to address redness, swelling, and bacterial overgrowth on the skin or mucosal surfaces.
This topical liquid should be applied directly to the affected area as directed by your healthcare professional. Cleanse the area gently before use and apply the liquid with a sterile applicator, avoiding contact with the eyes unless instructed otherwise.
Even though Dexamethasone Sodium Phosphate and Sulfacetamide are used in ophthalmological preparations, the formulation of this specific topical liquid is intended for skin or mucosal surface application. Do not apply this medication to your eyes without the guidance of a healthcare professional.
Side effects may include itching, redness, irritation, or dryness at the application site. More serious side effects could occur, such as skin thinning or worsening of infections. If you experience any severe or concerning reactions, contact your healthcare provider promptly.
The frequency of application for this topical liquid should be based on your healthcare provider's prescription, which often varies according to the severity and type of condition being treated.
Pregnant women should use this medication only if it is clearly needed and prescribed by a healthcare provider, as certain drugs can be absorbed through the skin and could potentially affect the fetus.
Your healthcare provider will inform you if you should cover the treated area. In some cases, covering the area can increase absorption of the medication, which may or may not be desired based on your treatment plan.
Use in children should be closely monitored by a pediatrician or healthcare provider, as children may be more sensitive to the effects of topical corticosteroids.
While this topical liquid is safe for use on many skin areas, certain sites such as the face, groin, or underarms may be more sensitive. Use caution and follow your healthcare provider's directions when applying the medication to these areas.
If you miss a dose of the Dexamethasone Sodium Phosphate/Sulfacetamide Topical Liquid, apply it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular application schedule. Do not apply extra medication to make up for a missed dose.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.